Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc., as indicated in the metadata) on November 10, 2011, reporting events occurring on November 9, 2011. The filing serves to announce the Company's financial results for the three and nine-month periods ended September 30, 2011, via a press release attached as Exhibit 99.01.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.01), which is incorporated by reference but not included in the source text provided.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. It only confirms the issuance of results for the periods ended September 30, 2011.
Guidance, Outlook, and Risks
The filing includes a standard Regulation FD disclosure and a disclaimer stating that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act. No specific guidance, outlook, management commentary, or risk factors are detailed within the text of this 8-K form itself.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Exhibit 99.01 Press Release dated November 9, 2011.
- Confirm the discrepancy between the metadata company name ("Palisade Bio, Inc.") and the actual registrant ("Neuralstem, Inc.").
- Review the full press release for any forward-looking statements or operational updates not summarized in this 8-K.